Related references
Note: Only part of the references are listed.Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice
Saeed Shanehsazzadeh et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2013)
Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging
Jack Hoppin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Specific Targeting of Breast Tumor by Octreotide-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 3.0-Tesla Magnetic Resonance Scanner
Xubin Li et al.
ACTA RADIOLOGICA (2009)
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Ruirui Qiao et al.
JOURNAL OF MATERIALS CHEMISTRY (2009)
Superparamagnetic Iron Oxide Nanoparticles as a Dual Imaging Probe for Targeting Hepatocytes In Vivo
Chang-Moon Lee et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
Thomas Schluep et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications
Sophie Laurent et al.
CHEMICAL REVIEWS (2008)
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
New technologies for human cancer imaging
John V. Frangioni
JOURNAL OF CLINICAL ONCOLOGY (2008)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Detection of hepatocellular carcinoma using 11C-choline PET:: Comparison with 18F-FDG PET
Yuka Yamamoto et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis
N. Snowberger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft
Wouter B. Nagengast et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
AX Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: Correlation of pretransplantation sonography and liver explant pathology in 200 patients
GL Bennett et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
